Skip to main content
. 2020 Jan 14;13:1. doi: 10.1186/s40545-019-0198-6

Table 3.

SPCs status of TDF/FTC and access to PrEP

TDF/FTC The Netherlands Belgium UK Denmark Norway France Germany Switzerland Ireland
SPC Rejected Preliminary injunction rejected Preliminary injunction rejected Maintained No information Revoked Revoked Maintained Preliminary injunction granted
Prices listed Average retail price [107] Ex-factory price (excluding taxes) [108] Reference price [109] Retail price [110] Maximum retail price [111] Ex-factory price (excluding taxes) [112] Retail price [113, 114] Reference price [115] Retail price [116]
Truvada price 344 380 402 1110 550 295 819 773 400
Cheapest available generic price 48 N/A N/A N/A 243 139 53 N/A 85
Originator - generic price difference 86% N/A N/A N/A 56% 53% 94% N/A 79%
Generic available on the market Yes [117] No [103] No [118] No [99] Yes [111] Yes [119] Yes [120] No [115] Yes [121]
Reimbursement Yes [122] Yes [123] No [124, 125] No information Yes [126] Yes [119] Pending [127] No [128] No [129]

Prices are in euro for 30 oral doses of TDF/FTC on 23 July 2018. Local currencies were converted to euro on 23 July 2018 [130]